Intranasal Steroid Therapy for Allergic Rhinitis

Allergic rhinitis (AR) is a common medical condition in children. It is associated with significant morbidity because symptoms can adversely affect quality of life. The goals of treatment of AR are to provide effective prevention as well as symptom alleviation. Pharmacotherapy is often necessary for...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric annals 2019-01, Vol.48 (1), p.e43-48
Main Authors: Seth, Divya, Kamat, Deepak
Format: Article
Language:English
Subjects:
Adolescents
Age
Allergies
Allergy
Asthma
Children & youth
Cold remedies
Drug dosages
Gene expression
Headaches
Histamine
Learning Problems
Meta Analysis
Narcotics
Nose
Patients
Pediatrics
Quality of life
Rhinitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Allergic rhinitis (AR) is a common medical condition in children. It is associated with significant morbidity because symptoms can adversely affect quality of life. The goals of treatment of AR are to provide effective prevention as well as symptom alleviation. Pharmacotherapy is often necessary for the reduction of symptoms and the associated morbidity. Intranasal steroids (INS) are highly effective drugs for treatment of AR and are more efficacious compared to other medications used to treat AR such as antihistamines and leukotriene modifiers. Several formulations of INS are available, all of which have approximately the same efficacy and safety profile. The most common adverse effect is local irritation. Systemic absorption from nasal mucosa is low and thus systemic effects are rare. However, prolonged use of INS, especially in patients who are also using oral or inhaled steroids, can result in hypothalamic-pituitary-axis suppression. [Pediatr Ann. 2019;48(1):e43-e48.].
ISSN:0090-4481
1938-2359
DOI:10.3928/19382359-20181212-01